Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies

被引：3

作者：

Einsele, Hermann ^{[1
]}

Briones, Javier ^{[2
]}

Ciceri, Fabio ^{[3
,4
]}

Garcia-Cadenas, Irene ^{[2
]}

Falkenburg, Fred ^{[5
]}

Bolanos, Natacha ^{[6
]}

Heemskerk, H. M. Mirjam ^{[5
]}

Houot, Roch ^{[7
,8
]}

Hudecek, Michael ^{[1
]}

Locatelli, Franco ^{[9
]}

Morgan, Kate ^{[10
]}

Morris, C. Emma ^{[11
]}

O'Dwyer, Michael ^{[12
,13
]}

Gil, Jordi Sierra ^{[2
,14
,15
]}

van den Brink, Marcel ^{[16
]}

van de Loosdrecht, Arjan A. ^{[17
]}

机构：

[1] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany

[2] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[3] Univ Vita Salute San Raffaele, Milan, Italy

[4] IRCCS San Raffaele Sci Inst, Div Transplantat Immunol & Transplantat Dis, Milan, Italy

[5] Leiden Univ Med Ctr, Dept Hematol, Leiden, Netherlands

[6] Lymphoma Coalit Europe, Madrid, Spain

[7] Univ Rennes, CHU Rennes, INSERM U1236, Rennes, France

[8] Dana Farber Canc Inst, Boston, MA 02115 USA

[9] Sapienza Univ Rome, Bambino Gesu Childrens Hosp, IRCCS, Rome, Italy

[10] Myeloma UK, Edinburgh, Midlothian, Scotland

[11] Royal Free Hosp, UCL Inst Immun & Transplantat, London, England

[12] Univ Hosp Galway, Dept Haematol, Galway, Ireland

[13] Natl Univ Ireland, Galway, Ireland

[14] St Pau Biomed Res Inst, Barcelona, Spain

[15] Jose Carreras Leukemia Res Inst, Barcelona, Spain

[16] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[17] Vrije Univ Amsterdam Med Ctr, Amsterdam UMC, Amsterdam, Netherlands

来源：

HEMASPHERE | 2020年 / 4卷 / 04期

关键词：

MINOR HISTOCOMPATIBILITY ANTIGENS; DELTA-T-CELLS; MONOCLONAL-ANTIBODIES; CHECKPOINT INHIBITION; THERAPEUTIC VACCINES; CANCER-IMMUNOTHERAPY; CMV INFECTION; PD-1; BLOCKADE; STEM-CELL; LEUKEMIA;

D O I：

10.1097/HS9.0000000000000423

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：5

共 50 条

[21] Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
Tapia-Galisteo, Antonio
alvarez-Vallina, Luis
Sanz, Laura
[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
[22] Histone deacetylases and epigenetic therapies of hematological malignancies
Mercurio, Ciro
Minucci, Saverio
Pelicci, Pier Giuseppe
[J]. PHARMACOLOGICAL RESEARCH, 2010, 62 (01) : 18 - 34
[23] Epigenetically - Targeted Therapies for the Treatment of Hematological Malignancies
Georgiou, E.
Kouidou, S.
[J]. CURRENT MEDICINAL CHEMISTRY, 2011, 18 (12) : 1757 - 1764
[24] Antibody-directed therapies for hematological malignancies
Linenberger, ML
Maloney, DG
Bernstein, ID
[J]. TRENDS IN MOLECULAR MEDICINE, 2002, 8 (02) : 69 - 76
[25] Milatuzumab: A new agent for the immunotherapy of hematological malignancies
Stein, R.
Goldenberg, D. M.
[J]. ANNALS OF ONCOLOGY, 2008, 19 : 29 - 30
[26] T cell modulation in immunotherapy for hematological malignancies
Lin, Chen
Chen, Shaohua
Li, Yangqiu
[J]. CELL BIOLOGY AND TOXICOLOGY, 2017, 33 (04) : 323 - 327
[27] Hematological malignancies
Brenner, MK
[J]. FASEB JOURNAL, 1997, 11 (08): : 640 - 648
[28] Guest editorial: advances in immunotherapy for hematological malignancies
Norimitsu Kadowaki
[J]. International Journal of Hematology, 2018, 107 : 260 - 261
[29] Immunotherapy of hematological malignancies using dendritic cells
De Velde, Ann L. R. Van
Berneman, Zwi N.
Van Tendeloo, Viggo F. I.
[J]. BULLETIN DU CANCER, 2008, 95 (03) : 320 - 326
[30] Cellular immunotherapy as a beacon of hope for hematological malignancies
Lee, Hyun-Ju
Kim, Sang-Ki
Cho, Duck
Lee, Je-Jung
[J]. BLOOD RESEARCH, 2015, 50 (03) : 126 - 128

← 1 2 3 4 5 →